Design, synthesis and biological evaluation of sulfenimine cephalosporin analogues as β-lactamase inhibitors

Abstract

A series of sulfenimine cephalosporin derivatives(6a—6t) was designed, synthesized and evaluated for their inhibitory activity against class A β-lactamase(TEM-1) derived from E. coli, and class C β-lactamase (cephalosporinase) derived from wild Bacillus subtilis in cell-free systems. Most of the tested compounds showed enhanced inhibitory activity against class C β-lactamase(cephalosporinase) compared with tazobactam. The most promising compounds 6c and 6o in combination with cefradine(IC₅₀=1.80 and 1.59 μmol/L, respectively) were further investigated against a series of clinical isolated β-lactamase-producing bacterial strains. The results reveal that compounds 6c and 6o in combination with cefradine show two to four times more activity than cefradine alone against methicillin-sensitive Staphylococcus aureus(MSSA) and Klebsiella pneumoniae. The data suggest that the sulfenimine moiety may be beneficial to the activity and selectivity of inhibitors.

Keywords

β-Lactamase-inhibitor / Sulfenimine / Cephalosporins

References

[1] Dax S. L. Antibacterial Chemotherapeutic Agents, 1997.

[2] Buynak J. D., Vogeti L., Doppalapudi V. R., Solomon G. M., Chen H. S. Bioorg. Med. Chem. Lett., 2002, 12: 1663.

[3] Venkatesan A. M., Agarwal A., Abe T., Ushirogochi H., Yamamura I., Kumagai T., Petersen P. J., Weiss W. J., Lenoy E., Yang Y. J., Shlaes D. M., Ryan J. L., Mansour T. S. Bioorg. Med. Chem., 2004, 12: 5807.

[4] Sandanayaka V. P., Prashad A. S. Curr. Med. Chem., 2002, 9: 1145.

[5] Micetich R. G., Salama S. M., Maiti S. N., Reddy A. V. N., Singh R. Curr. Med. Chem. Anti-Infect. Agents, 2002, 9: 193.

[6] Drawz S. M., Bonomo R. A. Clin. Microb. Rev., 2010, 23: 160.

[7] Rice L. B., Bonomo R. A. Drug Resist. Updates, 2000, 3: 178.

[8] Reading C., Farmer T. Biochem. J., 1981, 199: 779.

[9] English A. R., Retsema J. A., Girard A. E., Lynch J. E., Barth W. E. Antimicrob. Agents Chemother, 1978, 14: 414.

[10] Micetich R. G., Maiti S. N., Spevak P., Hall T. W., Yamabe S., Ishida N., Tanaka M., Yamazaki T., Nakai A., Ogawa K. J. Med. Chem., 1987, 30: 1469.

[11] Bitha P., Li Z., Francisco G. D., Yang Y. J., Petersen P. J., Lenoy E., Lin Y. I. Bioorg. Med. Chem. Lett., 1999, 9: 997.

[12] Clin. Infect. Dis., 1997, 24(1):

[13] Coleman K., Griffind D. R. J., Page J. W. J., Upshon P. A. Antimicrob. Agents Chemother, 1989, 33: 1580.

[14] Buynak J. D., Srinivasa R. A., Doppalapudi V. R., Adam G., Petersen P. J., Nidamarthy S. D. Bioorg. Med. Chem. Lett., 1999, 9: 1997.

[15] Liu D., Fan Z. C., Jiang J. M., Wei J., Xin J. C. Chem. Res. Chinese Universities, 2013, 29(4): 706.

[16] Yang H. K., Xu W. F., Duan A. N., You W. W., Zhao P. L. Chem. J. Chinese Universities, 2014, 35(3): 555.

[17] Zhang K., Cai J. J., Song H. R., Fu D. C. The 9th International Symposium for Chinese Medicinal Chemists, 2014, Shenyang: Shenyang Pharmaceutical University 234.

[18] Nottingham M., Bethel C. R., Pagadala S. R. R., Harry E., Pinto A., Lemons Z. A., Drawz S. M., Akker F., Carey P. R., Bonomo R. A., Buynak J. D. Bioorg. Med. Chem. Lett., 2011, 21: 387.

[19] Fu D. C., Li Z. W., Kang Y., Xu C. B., Li H., Cai J. J. Method for Preparation of 7-Amino-3-nor-3-cephem-4-carboxylic Acid, 2011.

[20] Saikawa I., Takano S., Momonoi K., Takakura I., Tanaka K., Kutani C. Chem. Pharm. Bull., 1985, 33: 5534.

[21] Gordon E. M., Chang H. W., Cimarusti C. M. J. Am. Chem. Soc., 1977, 99: 5504.

[22] Gordon E. M., Pluscec J. Tetrahedron Lett., 1983, 24: 3419.

[23] Boyd D. B., Herron D. K., Lunn W. H. W., Spitzer W. A. J. Am. Chem. Soc., 1980, 102: 1812.

[24] Faraci W. S., Pratt R. F. Biochemistry, 1985, 24: 903.

[25] Buynak J. D., Wu K. C., Bachmann B., Khasnis D., Hua L., Nguyen H. K., Carver C. L. J. Med. Chem., 1995, 38: 1022.